Two new missense mutations of GAA in late onset glycogen storage disease type II

被引:13
作者
Park, Young-Eun
Park, Kyu-Hyun
Lee, Chang-Hoon
Kim, Cheol-Min
Kim, Dae-Seong
机构
[1] Pusan Natl Univ, Sch Med, Med Res Inst, Dept Neurol, Pusan 602739, South Korea
[2] Pusan Natl Univ, Sch Med, Dept Pathol, Pusan 602739, South Korea
[3] Pusan Natl Univ, Sch Med, Dept Biochem, Pusan 602739, South Korea
关键词
glycogen storage disease type II; late onset; GAA; missense mutation;
D O I
10.1016/j.jns.2006.09.012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Glycogen storage disease type II(GSD II) is an autosomal recessive disorder resulting from a deficiency of acid alpha-glucosidase (GAA, or acid maltase). In this study, we aimed to characterize phenotype and genotype in three patients with late onset GSD II in Korea. Clinically, all of our patients showed typical features of late onset GSD II with the reduced GAA enzyme activities. The respiratory difficulty preceding ambulatory failure seems to be one of the most remarkable clinical features characterizing late onset GSD II. By direct sequence analysis of PCR-amplified genomic DNA obtained from patients' skeletal muscle or peripheral leukocytes, we identified four missense mutations. Two of them (p.266Pro > Ser and p.439Met > Lys) were new missense mutations causing late onset GSD 11, which had not been reported elsewhere before. One of them (p.439Met > Lys) was found in two alleles from each patient, suggesting it could be a recurrent mutation among Korean population. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:113 / 117
页数:5
相关论文
共 32 条
  • [1] Adams EM, 1997, HUM MUTAT, V10, P128, DOI 10.1002/(SICI)1098-1004(1997)10:2<128::AID-HUMU5>3.0.CO
  • [2] 2-G
  • [3] Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II:: Results of a phase I/II clinical trial
    Amalfitano, A
    Bengur, AR
    Morse, RP
    Majure, JM
    Case, LE
    Veerling, DL
    Mackey, J
    Kishnani, P
    Smith, W
    McVie-Wylie, A
    Sullivan, JA
    Hoganson, GE
    Phillips, JA
    Schaefer, GB
    Charrow, J
    Ware, RE
    Bossen, EH
    Chen, YT
    [J]. GENETICS IN MEDICINE, 2001, 3 (02) : 132 - 138
  • [4] Severe form of type II glycogenosis in a heterozygote compound (Tyr-292→Cys/Arg-854→stop) child
    Castro-Gago, M
    Eirís-Puñal, J
    Rodriguez-Núñez, A
    Pintos-Martínez, E
    Benlloch-Marín, T
    Barros-Angueira, F
    [J]. REVISTA DE NEUROLOGIA, 1999, 29 (01) : 46 - 49
  • [5] ENGEL AG, 2004, MYOLOGY, P1533
  • [6] Identification of six novel mutations in the acid alpha-glucosidase gene in three Spanish patients with infantile onset glycogen storage disease type II (Pompe disease)
    Fernandez-Hojas, R
    Huie, ML
    Navarro, C
    Dominguez, C
    Roig, M
    Lopez-Coronas, D
    Teijeira, S
    Anyane-Yeboa, K
    Hirschhorn, R
    [J]. NEUROMUSCULAR DISORDERS, 2002, 12 (02) : 159 - 166
  • [7] THE EFFECT OF A SINGLE-BASE PAIR DELETION (DELTA-T525) AND A C1634T MISSENSE MUTATION (PRO545LEU) ON THE EXPRESSION OF LYSOSOMAL ALPHA-GLUCOSIDASE IN PATIENTS WITH GLYCOGEN-STORAGE-DISEASE TYPE-II
    HERMANS, MMP
    DEGRAAFF, E
    KROOS, MA
    MOHKAMSING, S
    EUSSEN, BJ
    JOOSSE, M
    WILLEMSEN, R
    KLEIJER, WJ
    OOSTRA, BA
    REUSER, AJJ
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (12) : 2213 - 2218
  • [8] Twenty-two novel mutations in the lysosomal α-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II
    Hermans, MMP
    van Leenen, D
    Kroos, MA
    Beesley, CE
    Van der Ploeg, AT
    Sakuraba, H
    Wevers, R
    Kleijer, W
    Michelakakis, H
    Kirk, ER
    Fletcher, J
    Bosshard, N
    Basel-Vanagaite, L
    Besley, G
    Reuser, AJJ
    [J]. HUMAN MUTATION, 2004, 23 (01) : 47 - 56
  • [9] CHARACTERIZATION OF THE HUMAN LYSOSOMAL ALPHA-GLUCOSIDASE GENE
    HOEFSLOOT, LH
    HOOGEVEENWESTERVELD, M
    REUSER, AJJ
    OOSTRA, BA
    [J]. BIOCHEMICAL JOURNAL, 1990, 272 (02) : 493 - 497
  • [10] HUIE ML, 1994, HUM MOL GENET, V3, P2231